Results 31 to 40 of about 489,862 (290)

Managing tumor lysis syndrome

open access: yesJAAPA, 2021
ABSTRACT Tumor lysis syndrome (TLS) is one of the most common oncologic emergencies, occurring when tumor cell contents are rapidly released into the bloodstream. This release of cellular contents, including uric acid, phosphate, and potassium, can rapidly overwhelm the body's homeostasis mechanisms, leading to renal failure, seizures ...
openaire   +3 more sources

Tumor lysis syndrome developing intraoperatively

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2011
Tumor lysis syndrome is a potentially life threatening condition which is most commonly encountered in patients being treated with chemotherapy. We report a case of spontaneous tumor lysis syndrome that developed intraoperatively in a patient with ...
Ankur Verma   +3 more
doaj   +1 more source

Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells. [PDF]

open access: yes, 2015
We have recently shown that Natural Killer (NK) cells control survival and differentiation of Cancer Stem-like Cells (CSCs) through two distinct phenotypes of cytotoxic and anergic NK cells, respectively. In this report, brain CSCs and their serum and NK
Bui, Vickie T   +6 more
core   +1 more source

Nanobody based dual specific CARs [PDF]

open access: yes, 2018
Recent clinical trials have shown that adoptive chimeric antigen receptor (CAR) T cell therapy is a very potent and possibly curative option in the treatment of B cell leukemias and lymphomas.
Abken, Hinrich   +8 more
core   +5 more sources

Acute tumor lysis syndrome after proximal splenic artery embolization

open access: yesRadiology Case Reports, 2016
Preoperative splenic artery embolization for massive splenomegaly has been shown to reduce intraoperative hemorrhage during splenectomy. We describe a case of tumor lysis syndrome after proximal splenic artery embolization in a patient with advanced ...
Jason T. Salsamendi   +4 more
doaj   +1 more source

Hematological malignancies presenting as spontaneous tumor lysis syndrome: A case series

open access: yesJournal of Family Medicine and Primary Care, 2018
Tumor lysis syndrome is an oncological emergency caused by massive tumor lysis resulting in a constellation of metabolic abnormalities. It is observed most frequently in patients with high-grade hematological malignancies undergoing treatment.
Shehla Basheer Kollathodi   +3 more
doaj   +1 more source

ELECTROCHEMICAL LYSIS IN ONCOLOGY: LITERATURE REVIEW

open access: yesСибирский онкологический журнал, 2021
Recently, minimally invasive treatment modalities based on the application of various physical factors have been widely used in anticancer therapy. Electrochemical lysis is a method in which tumor cells are destroyed by local exposure to a constant low ...
E. V. Anikanova   +3 more
doaj   +1 more source

Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines [PDF]

open access: yes, 2000
In order to investigate the correlations between constitutive proteinase expression and the degree of tumorigenicity of cancer cells we have studied a model system of three keratinocyte cell lines.
Bachmeier, B. E.   +4 more
core   +1 more source

Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35

open access: yesMolecular Therapy: Oncolytics, 2021
Oncolytic adenoviruses (OAds) are among the most promising oncolytic viruses. Almost all oncolytic adenoviruses are composed of human adenovirus serotype 5 (Ad5) (OAd5).
Ryosuke Ono   +3 more
doaj   +1 more source

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. [PDF]

open access: yes, 2018
Peritoneal metastasis (PM) is an advanced stage malignancy largely refractory to modern therapy. Intraperitoneal (IP) immunotherapy offers a novel approach for the control of regional disease of the peritoneal cavity by breaking immune tolerance.
Bowne, Wilbur B.   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy